Company: DNLI
Filing Date: 2025-07-07
Form Type: 8-K
Source: 0001714899-25-000146
Chunk: 1

Company: Denali Therapeutics Inc.
Filing Date: 2025-07-07
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                  
         99.1      Press release dated July 7, 2025.                            
 ────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (formatted as Inline XBRL)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               DENALI THERAPEUTICS INC.                                             
  Date:      July 7, 2025      By:                           /s/ Alexander O. Schuth                
                                                             Alexander O. Schuth, M. D.             
                                                             Chief Operating and Financial Officer